Viralgen
Blood & Organ Banks · Spain · 201-500 Employees
View Company Info for Free
Overview
Headquarters
Paseo Mikeletegi 83, San Sebastian, Basq...Phone Number
+34 943477733Website
www.viralgenvc.comRevenue
$84.5 MillionIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
2
2
About Viralgen
Viralgen is a leading contract development and manufacturing organization (CDMO) specializing in AAV-based gene therapy manufacturing. They offer comprehensive services from process development to commercial production, all aimed at helping clients bring innovative therapies to patients with genetic diseases. With a strong focus on quality and regulatory support, Viralgen's facilities in San Sebastián, Spain, are equipped to handle a wide range of production scales. Their goal is to efficiently advance gene therapies through sustainable practices and customer-focused solutions.Explore more
Popular SearchesViralgenViral Gene IncViralgen Vector CoreViralgen Vector Core SlDulcera Garca IncSIC Code 28,283NAICS Code 32,325Show moreViralgen Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Viralgen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Viralgen is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Viralgen
Product Launch: Get notified when Viralgen launches new products
Click to see if Viralgen had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Viralgen has new funding data
Earning: See what the market has to say on Viralgen recently announced quarterly report
Check if Viralgen has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Viralgen, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Viralgen is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Viralgen is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Viralgen.
Viralgen Tech Stack
A closer look at the technologies used by Viralgen
See more technologies
Most Recent Scoops
Person-Based
Person-Based
Person-Based
Person-Based
Person-Based
Viralgen News & Media
Viralgen collaborates with Trogenix to advance AAV gene therapy for glioblastoma
Viralgen accelerates clinical development process: scaling manufacturing and completing GMP production of Trogenix's AAV gene therapy in under 12 months. SAN SEBASTIÁN, May 6, 2025 /PRNewswire/ -- Viralgen, a leading contract development and manufacturing organization (CDMO) specializing...Axovia Therapeutics receives grant from A Race Against Blindness to support upcoming clinical trial
The trial will feature the company’s product candidate, AXV101, focused on combating childhood blindness due to retinitis pigmentosa (RP) caused by Bardet-Biedl Syndrome 1 (BBS1).Viralgen and CTNNB1 Foundation partner to manufacture a new gene therapy for CTNNB1 Syndrome
Patients with CTNNB1 Syndrome will benefit from this joint effort to develop and manufacture a new AAV investigational gene therapy, which aims to restore gene function and may improve quality of life. SAN SEBASTIÁN, Spain and LJUBLJANA, Slovenia, Feb. 5, 2025 /PRNewswire/ -- Viralgen and...Viralgen and Axovia partner to manufacture an investigational gene therapy for retinal dystrophy in Bardet-Biedl Syndrome (BBS) patients
Collaborative effort will bring hope to BBS patients suffering from retinal degeneration through this investigational gene therapy. SAN SEBASTIÁN, Spain and LONDON, Jan. 22, 2025 /PRNewswire/ -- Viralgen and Axovia Therapeutics are joining forces to advance the development and manufacture...
Read more news
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Viralgen
Sign Up For FreeTo access detailed company insights
Viralgen is a leading contract development and manufacturing organization (CDMO) specializing in AAV-based gene therapy manufacturing. They offer comprehensive services from process development to commercial production, all aimed at helping clients bring innovative therapies to patients with genetic diseases. With a strong focus on quality and regu... Read More
